+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Injection Devices for Subcutaneous Self-administration to 2028

  • PDF Icon

    Report

  • 250 Pages
  • April 2022
  • Region: Global
  • Greystone Associates
  • ID: 5567617

Devices, Markets, Therapeutics, Strategies & Forecasts

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.


Injection Devices for Subcutaneous Self-administration: What You Will Learn

  • Provides detailed analysis of subcutaneous drug products, drug delivery and device strategies, and product development factors
  • Assesses key markets, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates SC drug products in nine key therapeutic segments
  • Provides market data and forecasts to 2028
  • Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of alliances and partnerships on subcutaneous drug product commercialization
  • Evaluates the impact of economic, technology, and regulatory factor

Table of Contents

  1. Executive Summary
  2. The Market Opportunity
  3. Delivery Market Dynamics
  4. The Economics of Injectable Drugs
  5. What’s Driving the Growth in Injectable Devices?
  6. Prefilled Syringes Proliferating
  7. The Trend toward Self-Administration
  8. Shifting Demographics
  9. Innovation in Disposable Device Designs
  10. Proliferation of Biological Drugs
  11. Therapeutic Monoclonal Antibodies
  12. Therapeutic Demand Drivers
  13. Competitive Landscape
  14. Risk Factors
  15. Autoinjectors - Commercial Devices
  16. Manual Injection Autoinjectors
  17. Automated Injection Autoinjectors
  18. Disposable Autoinjectors
  19. Molly (SHL Medical)
  20. Molly RNS (SHLMedical)
  21. Bertha (SHL Medical)
  22. Maggie (SHL Medical)
  23. Amber (SHL Medical)
  24. SafeLock (SHL Medical)
  25. VSDI +NIT (SHL Medical)
  26. SDI MIX +NIT (SHL Medical)
  27. Syrina S (Consort Medical)
  28. Syrina AS (Consort Medical)
  29. AutoJect 2 (Owen Mumford)
  30. SelfDose (West Pharmaceutical Services)
  31. Flexi-Q PFS (Elcam Medical)
  32. OTS Autoinjector (Consort Medical)
  33. Pro-Ject (Aptar)
  34. Consort Medical ASI
  35. Ypsomed VarioJect
  36. Rotaject Technology (SHL Medical)
  37. Viscala Autoinjector (Consort Medical)
  38. Flexi-Q HV (Elcam Medical)
  39. Intevia (Becton Dickinson)
  40. Antares Pharma Autoinjectors
  41. Dali Medical Devices
  42. Development-stage Autoinjectors
  43. NIS Autoinjector (Midas Pharma)
  44. ArQ - (Oval Medical)
  45. Wirelessly Enabled Autoinjectors
  46. BETACONNECT (Bayer)
  47. RebiSmart (Merck Serono)
  48. Selected Product Specific Autoinjectors
  49. Alsuma/Sumatriptan Autoinjector
  50. Sumatriptan (Dr. Reddy’s)
  51. Rebif/Rebidose (Merck Serono)
  52. Aimovig (Amgen/Novartis)
  53. Enbrel Mini AutoTouch (Amgen)
  54. Pegasys Proclick (Genentech/Roche)
  55. Otrexup (Antares Pharma)
  56. Evzio (Kaleo)
  57. Autoinjector Device Design Factors
  58. Material Selection Issues
  59. Part Counts and Device Cost
  60. Safety Features
  61. Needle Insertion Depth
  62. Failsafe Activation
  63. Dose Inspection/Injection Confirmation
  64. Lyophilized Drugs/Reconstitution
  65. Human Engineering/Ergonomics
  66. Pen Injectors
  67. Pen Injector Design Selection Factors
  68. Standardized Pen Platforms
  69. Haselmeier
  70. Becton Dickinson
  71. Owen Mumford
  72. Autoject2
  73. Ypsomed
  74. SHL Medical
  75. Custom Pen Designs
  76. Reusable Pens
  77. Dual Chamber Pens
  78. Commercial Pen Products
  79. Genotropin Pen
  80. Humatro-Pen/Humatro Pen 3
  81. Norditropin
  82. NordiPenmate
  83. Nutropin AQ Pen
  84. Omnitrope
  85. One.Click
  86. Lantus/Toujeo (Insulin Glargine)
  87. Diapen
  88. Gansulin Pen
  89. Flexpen (Novo Nordisk)
  90. Humalog Pen/KwikPen
  91. HumaPen Memoir
  92. HumaPen Luxura HD
  93. NovoPen (Novo Nordisk)
  94. SoloStar
  95. Byetta Pen
  96. Bydureon
  97. SymlinPen
  98. Saxenda (Liraglutide)
  99. Tanzeum (Abliglutide)
  100. Trulicity (Dulaglutide)
  101. Victoza (Liraglutide)
  102. Parathyroid Hormone
  103. Forteo Pen
  104. Preotact/Preos
  105. Natpara
  106. Reproductive Hormones
  107. Follistim/Puregon Pen
  108. Gonal-f
  109. Wearable Devices - Product Analysis and Assessments
  110. Libertas (Becton Dickinson)
  111. Patch Pump (Sensile Medical)
  112. SmartDose (West Pharmaceuticals)
  113. Neulasta OnPro Injector (Insulet/Amgen)
  114. YpsoDose (Ypsomed)
  115. Electronic Semi-disposable
  116. E3D Patch Pump (Elcam)
  117. Mechanical Disposable
  118. enFuse (Enable Injections)
  119. Captive Devices
  120. sc2Wear Infusor (scPharmaceuticals)
  121. PatchPump (SteadyMed)
  122. Wireless Data
  123. Key Therapeutic Sector Analysis
  124. Anaphylaxis/Countermeasures
  125. Autoimmune Diseases
  126. Rheumatoid Arthritis
  127. Psoriasis
  128. Multiple Sclerosis
  129. Exenatide (Byetta)
  130. Bydureon
  131. Pramlinitide (Symlin)
  132. Abliglutide (Tanzeum)
  133. Hepatitis
  134. Hormones
  135. Osteoporosis
  136. Market Factors
  137. Regulatory Issues
  138. Device Branding
  139. Patient Adherence and Ease of Use
  140. Healthcare Economics
  141. Company Profiles

Samples

Loading
LOADING...

Companies Mentioned

  • Amgen
  • Antares Pharma
  • Aptar
  • Bayer
  • Becton Dickinson
  • Consort Medical
  • Dr. Reddy’s
  • Elcam Medical
  • Genentech
  • Kaleo
  • Merck Serono
  • Midas Pharma
  • Novartis
  • Oval Medical
  • Owen Mumford
  • Roche
  • SHL Medical
  • West Pharmaceutical Services